Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism TREK1 stimulators(KCNK potassium channel-2 stimulators), TREK2 agonists(potassium two pore domain channel subfamily K member 10 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H8BrF4NO3S |
InChIKeyGIWMAACCICFCDQ-UHFFFAOYSA-N |
CAS Registry2361320-35-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 01 Jul 2019 | |
Inflammation | Preclinical | JP | 01 Jul 2019 |